852877-59-9 Usage
Uses
Used in Pharmaceutical Industry:
(3-Cyclopropylbenzyl)amine is used as a key intermediate in the synthesis of various drugs and biologically active molecules. Its unique chemical properties allow for the creation of diverse pharmaceutical compounds with potential therapeutic applications.
Used in Organic Synthesis:
(3-Cyclopropylbenzyl)amine is utilized as a building block in organic synthesis for the development of new chemical entities. Its cyclopropyl group provides a distinct structural element that can be further modified or functionalized to yield a variety of organic compounds.
Used in Catalytic Reactions:
(3-Cyclopropylbenzyl)amine has been studied for its potential use as a ligand in catalytic reactions. Its unique properties may enhance the efficiency and selectivity of certain catalytic processes, contributing to advancements in chemical synthesis and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 852877-59-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,2,8,7 and 7 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 852877-59:
(8*8)+(7*5)+(6*2)+(5*8)+(4*7)+(3*7)+(2*5)+(1*9)=219
219 % 10 = 9
So 852877-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N/c11-7-8-2-1-3-10(6-8)9-4-5-9/h1-3,6,9H,4-5,7,11H2
852877-59-9Relevant academic research and scientific papers
(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING
-
Page/Page column 81, (2009/05/29)
The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)
Macrocyclic Compounds Useful as Bace Inhibitors
-
Page/Page column 49, (2008/12/05)
The invention relates to novel macrocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16 or 17, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
